Delivery Order SPE2DB22D2206-SPE2DB25FFC98

Award Date 1/15/25
Potential Completion Date 1/16/25
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Ambien CR 12.5 mg tablets. The contract has a ceiling value of $1,633.35 and a period of performance through January 15, 2025. It is a firm fixed-price contract with no set-aside requirements, indicating open competition. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ambien CR 12.5 mg tablets. The contract is a firm-fixed-price, delivery order contract with a ceiling value of $1,659.74 and a period of performance through November 4, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,556.01 firm fixed-price contract is for the supply of AMBIEN CR 6.25 MG TABLET 100S, a prescription sleep medication. The contract has an ultimate completion date of January 13, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corp for the supply of AMBIEN CR 6.25 MG TABLET 100S. The $1,519.56 firm fixed price contract has a completion date of July 25, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds several indefinite delivery contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and $750,000 respectively, to provide a wide range of medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of AMBIEN CR 12.5 MG TABLET 100S, a prescription sleep medication, with a ceiling value of $2,267.44 and a performance period ending on August 16, 2024. The contract is a firm-fixed-price, non-set-aside vehicle. AmerisourceBergen, through its extensive federal contracting experience and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,829.97 fixed-price delivery order covers the supply of AMBIEN CR 12.5 MG TABLET 100S, a medication used for the treatment of insomnia. The contract has an ultimate completion date of January 6, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,087.36 firm-fixed-price delivery order covers the supply of AMBIEN CR 12.5 MG TABLET 100S, with a period of performance through January 17, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,343.28 contract is for the delivery of AMBIEN CR 12.5 MG TABLET 100S and has an ultimate completion date of January 14, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,926.86 delivery order contract is for the provision of AMBIEN CR 6.25 MG TABLET 100S, a sleep medication. The contract has a firm fixed price pricing type and a completion date of January 16, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of Ambien CR 6.25 mg tablets in 100-count bottles, with a ceiling value of $1,712.74 and an ultimate completion date of August 5, 2024. The contract is a firm fixed-price, delivery order type with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FFC98
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of AMBIEN CR 6.25 MG TABLET 100S. The contract has a ceiling value of $1,750.14 and a period of performance through January 16, 2025. The contract is a firm fixed-price arrangement. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not utilize any set-aside designations, indicating open competition.

Generated 4/21/25, 3:52 AM